KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Convertible Debt: 2016-2024

Historic Convertible Debt for Novavax (NVAX) over the last 9 years, with Dec 2024 value amounting to $169.7 million.

  • Novavax's Convertible Debt rose 44.06% to $243.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $243.8 million, marking a year-over-year increase of 44.06%. This contributed to the annual value of $169.7 million for FY2024, which is 0.99% up from last year.
  • As of FY2024, Novavax's Convertible Debt stood at $169.7 million, which was up 0.99% from $168.0 million recorded in FY2023.
  • Over the past 5 years, Novavax's Convertible Debt peaked at $323.5 million during FY2021, and registered a low of $166.5 million during FY2022.
  • In the last 3 years, Novavax's Convertible Debt had a median value of $168.0 million in 2023 and averaged $168.1 million.
  • Per our database at Business Quant, Novavax's Convertible Debt tumbled by 48.54% in 2022 and then increased by 0.99% in 2024.
  • Over the past 5 years, Novavax's Convertible Debt (Yearly) stood at $322.0 million in 2020, then grew by 0.44% to $323.5 million in 2021, then crashed by 48.54% to $166.5 million in 2022, then rose by 0.93% to $168.0 million in 2023, then climbed by 0.99% to $169.7 million in 2024.